LEHIGH VALLEY TOXICOLOGY, LLC v. CONTINENTAL CASUALTY COMPANY (CNA)

CourtDistrict Court, E.D. Pennsylvania
DecidedSeptember 3, 2025
Docket5:24-cv-06153
StatusUnknown

This text of LEHIGH VALLEY TOXICOLOGY, LLC v. CONTINENTAL CASUALTY COMPANY (CNA) (LEHIGH VALLEY TOXICOLOGY, LLC v. CONTINENTAL CASUALTY COMPANY (CNA)) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
LEHIGH VALLEY TOXICOLOGY, LLC v. CONTINENTAL CASUALTY COMPANY (CNA), (E.D. Pa. 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA __________________________________________

LEHIGH VALLEY TOXICOLOGY, LLC : doing business as : LEHIGH VALLEY GENOMICS, LLC, : Plaintiff, : : Civil No. 5:24-cv-06153-JMG v. : : CONTINENTAL CASUALTY COMPANY/CNA, : Defendant. : __________________________________________ MEMORANDUM OPINION GALLAGHER, J. August 29, 2025 I. OVERVIEW Plaintiff Lehigh Valley Toxicology seeks a declaratory finding that its insurer, Defendant, Continental Casualty Company, is obligated to indemnify and defend Plaintiff in a pending state court action. Both parties filed motions for judgment on the pleadings. For the following reasons, Defendant’s motion is granted, and Plaintiff’s motion is denied. II. FACTUAL BACKGROUND a. The Insurance Policies For the relevant time period, Plaintiff was insured by Defendant under two policies, the Commercial Package Insurance Policy (“Package Policy”) and the Commercial Umbrella Insurance Policy (“Umbrella Policy”). Exs. 1, 2, ECF No. 12. The Businessowner’s Liability Coverage Form provides that Defendant will be obligated to indemnify Plaintiff for damages caused by “bodily injury,” “property damage,” or “personal and advertising injury” to which the Package Policy applies. Ex. 1, ECF No. 12 at 131. Such policy further provides that Defendant is obligated to defend the insured against any suit seeking those damages. Ex. 1, ECF No. 12, at 117. “Personal and advertising injury,” as defined in the Package Policy, means injury, including consequential ‘bodily injury’ arising out of one or more of several listed offenses,

including “oral or written publication, in any manner, of material that slanders or libels a person or organization or disparages a person’s or organization’s goods, products or services.” Ex. 1, ECF No. 12 at 131. The Package Policy notably includes the following exclusions for personal and advertising injuries, which this Court will refer to as the “knowing publication exclusion”: “Personal and Advertising Injury”: (1) Caused by or at the direction of the insured with the knowledge that the act would violate the rights of another and would inflict “personal and advertising injury”; (2) Arising out of oral or written publication of material, if done by or at the direction of the insured with knowledge of its falsity;

Ex. 1, ECF No. 12 at 123. Additionally, the Package Policy excludes coverage for incidents resulting from the rendering or failure to render any professional service, referred to as the “professional services exclusion”: j. Professional Services “Bodily injury,” “property damage,” “personal and advertising injury: caused by the rendering or failure to render any professional service. This includes: (4) Medical, surgical, dental, x-ray or nursing services treatment, advice or instruction; (5) Any health or therapeutic service or treatment, advice or instruction; (9) Services in the practice of pharmacy This exclusion applies even if the claims allege negligence or other wrongdoing in the supervision, hiring, employment, training or monitoring of others by an insured, if the “occurrence” which caused the “bodily injury” or “property damage,” or the offense which caused the “personal and advertising injury,” involved the rendering or failure to render any professional service. Ex. 1, ECF No. 12 at 122. The Umbrella Policy serves as supplemental coverage to the Package Policy, extending the retained limit the insurer must supply if covered damages exceed the underlying policy’s limit. Accordingly, “in the event of any difference between the exclusions, restrictions, limiting terms, or conditions in this [Umbrella] Policy and [such terms] in the

[underlying Package Policy] . . . the more restrictive provision shall apply—as per the “Underlying Insurance Coverage Limitation.” Ex. 2, ECF No. 12 at 7. Accordingly, the aforementioned exclusions contained in the Package Policy may dictate coverage under both policies. Id. b. The Underlying Action

In the early stages of the Coronavirus pandemic, Chester County had contracted with Advaite, Inc. for the manufacturing and delivery of RapCov COVID-19 Rapid Test Antibody Kits. Ex. A, ECF No. 1 ¶¶ 13-15. Chester County also contracted with Plaintiff to provide laboratory services, including administering, reading, and processing these Covid tests for the residents of the county. Ex. A, ECF No. 1 ¶ 8. To be eligible for such a contract, a laboratory must have been certified as a High Complexity Clinical Laboratory Improvement Amendments (“CLIA”) Laboratory, which Plaintiff was. Ex. A, ECF No. 1 ¶¶ 2, 16. During discovery in a related state lawsuit with Chester County, Advaite deposed Lisa

Jackson, Plaintiff’s Managing Partner and Corporate Designee, who admitted that 1) Plaintiff did not follow the RapCov test kits’ instructions when administering the tests; 2) Plaintiff’s internal investigation into false positives revealed that there were no issues with the tests, instead that the supposed false positives were the result of improper use and reading of the tests by Plaintiff and County employees; 3) Plaintiff changed the results of the purported false positives without notifying patients; and 4) despite knowing that the RapCov test kits were not at fault for any discrepancy, Plaintiff sent out over 19,000 letters to Chester County residents on October 1, 2020, informing them that the test kits were unreliable. Ex. A, ECF No. 1, at ¶ 9. It was after learning the above facts that Advaite filed a complaint against Plaintiff seeking relief on four counts: I) breach of contract, II) tortious interference, III) negligence, and IV)

commercial disparagement and trade libel. Id. at ¶ 3. Plaintiff has waived its right to argue coverage based on Counts I or II of the Advaite Complaint, but further detail is required as to the remaining counts. ECF No. 22, at 18. Specifically, Count III alleges: 64. Defendant LVG had a duty to perform laboratory services accurately and properly. LVG breached this duty when it ignored Advaite’s IFU and its own validation study. 65. Further, Defendant LVG breached its duty when it failed to inform individuals who had been administered the RapCov test when their test results were changed, instead falsely informing them four months later that there was a defect in the RapCov test kits. 66. Defendant LVG’s breaches of duty damaged Plaintiff’s reputation and its future business prospects.

Ex. A, ECF No. 1 ¶¶ 64-66. And Count IV alleges: 69. Defendant LVG misinformed thousands of individuals who had been administered the RapCov test that the RapCov test kits had a defect despite its Corporate Designee’s admission under oath at her deposition that there were no issues with the RapCov test kits. 70. This misinformation was sufficiently disparaging and libelous, and LVG’s conduct sufficiently wrongful, wanton, egregious, and or malicious, to warrant the award of compensatory damages to Plaintiff and the imposition of punitive damages against LVG.

Ex. A, ECF No. 1 ¶¶ 69, 70. This court must, therefore, determine whether Defendant has a duty to defend and indemnify Plaintiff based on Counts III and IV of the underlying Advaite complaint. III. LEGAL STANDARD According to Federal Rule of Civil Procedure 12(c), “after the pleadings are closed—but early enough not to delay trial—a party may move for judgment on the pleadings.” Fed R. Civ. P. 12(c). The court analyzes a motion for judgment on the pleadings in the same manner as one for failure to state a claim under Rule 12(b)(6). Wolfington v. Reconstructive Orthopaedic Assocs. II

PC, 935 F.3d 187, 195 (3d Cir. 2019).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Mayer v. Belichick
605 F.3d 223 (Third Circuit, 2010)
William Selko v. Home Insurance Company
139 F.3d 146 (Third Circuit, 1998)
Weisman v. Green Tree Insurance
670 A.2d 160 (Superior Court of Pennsylvania, 1996)
Mutual Benefit Insurance v. Haver
725 A.2d 743 (Supreme Court of Pennsylvania, 1999)
Westport Insurance v. Black, Davis & Shue Agency, Inc.
513 F. Supp. 2d 157 (M.D. Pennsylvania, 2007)
Erie Insurance Exchange v. Transamerica Insurance
533 A.2d 1363 (Supreme Court of Pennsylvania, 1987)
General Accident Insurance Co. of America v. Allen
692 A.2d 1089 (Supreme Court of Pennsylvania, 1997)
Home Insurance v. Perlberger
900 F. Supp. 768 (E.D. Pennsylvania, 1995)
CGU Insurance v. Tyson Associates
140 F. Supp. 2d 415 (E.D. Pennsylvania, 2001)
401 Fourth Street, Inc. v. Investors Insurance Group
879 A.2d 166 (Supreme Court of Pennsylvania, 2005)
American & Foreign Insurance v. Jerry's Sport Center, Inc.
2 A.3d 526 (Supreme Court of Pennsylvania, 2010)
Transportation Insurance v. Pennsylvania Manufacturers' Ass'n
641 F. Supp. 2d 406 (E.D. Pennsylvania, 2008)
Pennsylvania National Mutual Casualty Insurance v. St. John
106 A.3d 1 (Supreme Court of Pennsylvania, 2014)
Ramara Inc v. Westfield Insurance Co
814 F.3d 660 (Third Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
LEHIGH VALLEY TOXICOLOGY, LLC v. CONTINENTAL CASUALTY COMPANY (CNA), Counsel Stack Legal Research, https://law.counselstack.com/opinion/lehigh-valley-toxicology-llc-v-continental-casualty-company-cna-paed-2025.